Nicolás Roche
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Inhalation and Respiratory Drug Delivery
- Pulmonary Hypertension Research and Treatments
- Respiratory and Cough-Related Research
- Physiology top 0.1%
- Asthma and respiratory diseases
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 240
- Respiratory Support and Mechanisms 82
- Inhalation and Respiratory Drug Delivery 61
- Respiratory and Cough-Related Research 59
- Physiology 187
- Asthma and respiratory diseases 172
- Co-authors
- Violaine Giraud (4 shared papers)David Price (58 shared papers)Pierre Regis Burgel (46 shared papers)Didier Pradon (46 shared papers)Thierry Perez (43 shared papers)Pascal Chanez (34 shared papers)Djamel Bensmaïl (53 shared papers)Claus Franz Vogelmeier (14 shared papers)
- Journals
- European Respiratory Journal (44 papers)Respiratory Medicine (27 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)Respiratory Research (18 papers)International Journal of COPD (17 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Nicolás Roche
614 papers receiving 30.0k citations
Nicolás Roche's Hit Papers
Peers
Comparison fields: 5 of 216
- Pulmonary and Respiratory Medicine 16.1k
- Physiology 6.5k
- Issues, ethics and legal aspects 220
- Immunology and Allergy 907
- Infectious Diseases 2.2k
Countries citing papers authored by Nicolás Roche
This map shows the geographic impact of Nicolás Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Roche more than expected).
Fields of papers citing papers by Nicolás Roche
This network shows the impact of papers produced by Nicolás Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Roche. The network helps show where Nicolás Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolás Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 659 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Hit paper breakdown → | 2017 | 2553 |
| 2 | 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Hit paper breakdown → | 2022 | 2323 |
| 3 | Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Hit paper breakdown → | 2020 | 2262 |
| 4 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 Hit paper breakdown → | 2019 | 1420 |
| 5 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Hit paper breakdown → | 2023 | 767 |
| 6 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 723 |
| 7 | Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD Hit paper breakdown → | 2016 | 639 |
| 8 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 553 |
| 9 | Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report Hit paper breakdown → | 2017 | 523 |
| 10 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Hit paper breakdown → | 2023 | 490 |
| 11 | Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial Hit paper breakdown → | 2018 | 467 |
| 12 | 2002 | 439 | |
| 13 | Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence Hit paper breakdown → | 2019 | 403 |
| 14 | 2020 | 334 | |
| 15 | 2008 | 304 | |
| 16 | 2010 | 275 | |
| 17 | 2017 | 270 | |
| 18 | 2017 | 257 | |
| 19 | 2000 | 206 | |
| 20 | 2020 | 196 |
About Nicolás Roche
Nicolás Roche is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Neurology, Rehabilitation and Physical Therapy, Sports Therapy and Rehabilitation, having authored 659 papers that have together received 30.9k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (240 papers), Asthma and respiratory diseases (172 papers), Respiratory Support and Mechanisms (82 papers), Inhalation and Respiratory Drug Delivery (61 papers), Respiratory and Cough-Related Research (59 papers), Botulinum Toxin and Related Neurological Disorders (35 papers), Stroke Rehabilitation and Recovery (21 papers) and Cerebral Palsy and Movement Disorders (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (16.1k citations), Physiology (6.5k citations), Issues, ethics and legal aspects (220 citations), Immunology and Allergy (907 citations) and Infectious Diseases (2.2k citations). Nicolás Roche has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Violaine Giraud, David Price, Pierre Regis Burgel, Didier Pradon, Thierry Perez, Pascal Chanez, Djamel Bensmaïl, Claus Franz Vogelmeier, ALBERTO PAPI and Gérard Huchon. Their work appears in journals such as European Respiratory Journal, Respiratory Medicine, American Journal of Respiratory and Critical Care Medicine, Respiratory Research and International Journal of COPD.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.